Trial Profile
Treatment of Chronic Post-Traumatic Headache With Onabotulinumtoxin A
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 26 Oct 2018
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Post-traumatic headache
- Focus Therapeutic Use
- 27 Feb 2017 Status changed from recruiting to discontinued.
- 08 Jul 2014 New trial record